Preclinical testing of 3 cysteine-related drugs for reducing dystropathology in the mdx mouse model of Duchenne Muscular Dystrophy

Arthur, Peter (Investigator 01)
Grounds, Miranda (Investigator 02)

Status	Finished
Effective start/end date	1/01/14 → 30/12/17

Funding

NHMRC National Health and Medical Research Council : A$366,174.00

Access Project

http://purl.org/au-research/grants/nhmrc/1065829

3 Article

Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction
Terrill, J. R., Pinniger, G. J., Nair, K. V., Grounds, M. D. & Arthur, P. G., 1 Nov 2017, In: PLoS One. 12, 11, e0187317.
Research output: Contribution to journal › Article › peer-review

Open Access
18 Citations (Scopus)
Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy
Terrill, J., Duong, M., Turner, R., Le Guiner, C., Boyatzis, A., Kettle, A. J., Grounds, M. & Arthur, P., Oct 2016, In: Redox Biology. 9, p. 276-286 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
40 Citations (Scopus)
Taurine deficiency, synthesis and transport in the mdx mouse model for Duchenne Muscular Dystrophy
Terrill, J., Grounds, M. & Arthur, P., Sept 2015, In: International Journal of Biochemistry and Cell Biology. 66, p. 141-148
Research output: Contribution to journal › Article › peer-review

Open Access
File
39 Citations (Scopus)

420 Downloads (Pure)